AeroVironment slides as SCAR/BADGER contract uncertainty keeps pressure on shares
AeroVironment shares fell 4.41% to $186.55 on March 27, 2026 as investors continued to price in disruption risk tied to the company’s BADGER phased-array antenna work under the U.S. SCAR program. The stock has faced weeks of selling pressure following the reported stop-work order/contract uncertainty and a series of analyst downgrades and target cuts.
1) What’s moving the stock
AeroVironment (AVAV) fell 4.41% to $186.55 in Friday trading (March 27, 2026) as investors continued to discount execution and revenue-visibility risk tied to the company’s Space Force-related SCAR program work, including the BADGER phased-array antenna contract. The overhang has persisted since early March, when contract uncertainty and subsequent negative research actions shifted sentiment from “war demand” upside to program-risk downside.
2) The key overhang: SCAR/BADGER disruption risk
The central issue for AVAV bulls and bears is whether BADGER/SCAR proceeds on the original trajectory, gets resized, or faces extended delays. Recent reporting has highlighted a stop-work order tied to the BADGER contract and the likelihood that any interruption would pressure the revenue ramp AVAV had expected in the second half of calendar 2026, keeping investors focused on backlog quality, margin trajectory, and the durability of growth assumptions for the Space, Cyber, and Directed Energy segment.
3) Why the selling pressure is lingering
Even after the company reported fiscal 2026 third-quarter results on March 10, investors have remained sensitive to guidance credibility and program concentration risk. In recent weeks, multiple Wall Street notes have pointed to the same theme—SCAR/BADGER uncertainty—driving downgrades and price-target reductions, which can amplify downside moves on otherwise quiet news days as buyers step back and volatility stays elevated.
4) What to watch next
Near-term direction likely hinges on any definitive government/program update that clarifies timing, scope, and economics of SCAR/BADGER work, as well as management commentary that ties funded backlog to deliverable revenue. Traders will also watch for additional research changes and any incremental SEC filings that could shift sentiment at the margin, including leadership-transition disclosures.